Quick read · 5 min

Managing hayfever during pregnancy

What's safe, what isn't, and how to decide

By Haelo

In short

What's safe, what isn't, and how to decide

Hayfever during pregnancy is common — affecting around 1 in 5 pregnant women — and notoriously harder to manage, because the standard treatment ladder shifts. Some medications are well-established as safe in pregnancy. Others are clearly to be avoided. A few sit in a middle zone where the conversation with your midwife or GP matters more than any general guidance.

This is the framework. It is not a substitute for clinical advice on your specific medications.

What is generally considered safe

Saline nasal rinse

The most strongly endorsed first-line treatment in pregnancy. Mechanical, non-pharmaceutical, no systemic absorption. Use a high-volume bottle or neti pot with sterile or pre-boiled water — never tap water.

Pregnant women often experience pregnancy rhinitis — congestion driven by elevated oestrogen and increased blood flow to nasal tissue — entirely separate from hayfever. Saline rinses help both.

Intranasal corticosteroids (most)

Several INCS are widely used in pregnancy and considered low-risk because so little is systemically absorbed.

  • Budesonide has the best safety data and is often the first choice.
  • Fluticasone propionate and mometasone furoate are also commonly used.
  • Beclomethasone has been used for decades with no clear safety signal.

The point of using INCS in pregnancy is the same as outside it — daily, consistent, started early. Talk to your midwife if you're newly starting one rather than continuing.

Loratadine and cetirizine

These are the two oral antihistamines with the largest body of safety data in pregnancy and are usually recommended as first-line if a tablet is needed. Both have been used by millions of pregnant women with no clear evidence of harm.

Cetirizine carries the small sedation risk it does outside pregnancy — fexofenadine or loratadine are alternatives if drowsiness matters.

What sits in the middle

Fexofenadine

Less safety data in pregnancy than loratadine or cetirizine, but no signal of harm. Many specialists will continue a woman on fexofenadine if she was already on it pre-pregnancy and finds it works well. Discuss with your midwife or GP.

Bilastine

Newer drug, much less pregnancy safety data. Most clinicians will switch to loratadine or cetirizine during pregnancy as a precaution.

Antihistamine eye drops

Topical olopatadine and azelastine have minimal systemic absorption and are generally considered low-risk. Discuss specifically with your midwife.

What to avoid

Pseudoephedrine and other oral decongestants

Vasoconstrictor effects. Possible association with congenital abnormalities in first trimester in some studies. Generally avoided throughout pregnancy.

Decongestant nasal sprays (oxymetazoline, xylometazoline)

Same vasoconstrictor concern, plus the rebound congestion problem that affects everyone.

First-generation antihistamines (diphenhydramine, chlorphenamine, promethazine)

These cross the placenta readily. While occasionally prescribed for specific obstetric reasons (notably promethazine for hyperemesis), they're not appropriate for routine hayfever management.

Oral steroids and montelukast

Not first-line. Decisions about these should be made by a specialist, not based on general guidance.

Non-medication strategy matters more in pregnancy

Because the pharmaceutical options are narrower, the environmental and behavioural side of the routine carries more weight than usual.

  • Bedroom setup: HEPA purifier, allergen-barrier covers, humidity below 50%, 60°C bedding wash. All standard, all safe.
  • Evening shower with hair wash before bed. Even more important than usual.
  • Saline rinses twice daily in peak season.
  • Wraparound sunglasses on commutes and walks.
  • Windows closed from sunrise; ventilate in the evening if needed.
  • Avoid drying laundry outside during pollen season.

Things to discuss specifically with your midwife or GP

  • Whether to continue a medication you were on before pregnancy
  • First-trimester specific concerns vs. later pregnancy
  • Whether to step up to a steroid spray or add eye drops
  • Anything you're being offered by a pharmacist that isn't on the safe list above
  • Severe symptoms that aren't responding to the safe options

Most midwives and GPs are comfortable with this conversation and will give you a clear answer for your specific situation.

The bottom line

You don't have to suffer through hayfever in pregnancy, and you don't have to take risks to manage it. Saline rinse plus a well-established INCS (often budesonide) plus loratadine or cetirizine is a strong, evidence-backed combination used routinely by women in pregnancy. Combined with the bedroom and behavioural side of the routine, it's enough for most women through peak season.


If a medication question isn't covered clearly here, the right next step is always your midwife or GP, not the internet, not a pharmacist's casual answer, and not the cautious assumption that everything is unsafe.

The evidence

What the research actually says

Each answer below is drawn from a graded research review. Confidence reflects the strength of the underlying evidence, not how confident we feel about it.

How does childhood hayfever differ from adult presentation?

Childhood allergic rhinitis differs from adult presentation in several key ways: children more commonly experience intermittent (seasonal) disease with higher classified severity despite lower subjective symptom scores, while adults tend toward persistent, perennial symptoms with greater self-reported burden. Children exhibit a stronger association with atopic comorbidities including asthma, conjunctivitis, atopic dermatitis, otitis media, and adenoid hypertrophy, whereas adults more frequently report sleep disturbance and work productivity loss. Quality of life impacts in children are predominantly expressed through impaired school performance, concentration difficulties, and developmental concerns rather than the occupational and sleep-related impairments dominant in adults.

How it works

The pediatric immune system is in an active sensitization phase, predisposing children to IgE-mediated polysensitization and the sequential progression of atopic march (eczema → rhinitis → asthma), driven by Th2-skewed immune responses and ongoing allergen exposure during critical developmental windows. Anatomical factors unique to children, including Eustachian tube immaturity and adenoidal tissue prominence, amplify nasal obstruction and predispose to middle ear and sinus complications not typically seen in adult disease.

Confidence: moderate

Can early-season treatment reduce severity?

Early-season and pre-seasonal treatment of allergic rhinitis is supported by evidence across multiple modalities, including intranasal corticosteroids (INCS), sublingual immunotherapy (SLIT), subcutaneous immunotherapy (SCIT), and omalizumab, all demonstrating reduced symptom severity compared to in-season or reactive treatment. A prospective RCT found preseasonal omalizumab (300mg ~2 weeks before pollen season) superior to standard medication, while pre- and co-seasonal SLIT regimens show consistent benefit in pollen-induced rhinoconjunctivitis. Early antihistamine initiation (e.g., fexofenadine before peak pollen) also showed reduced severity compared to delayed treatment initiation.

How it works

Pre-seasonal treatment allows anti-inflammatory and immunomodulatory effects to establish before allergen exposure peaks; INCS require 2-4 weeks to maximally downregulate inflammatory cells and vascular permeability, while immunotherapy progressively shifts immune responses from Th2-dominant toward tolerance, reducing IgE-mediated mast cell and basophil activation during the subsequent pollen season.

Confidence: moderate

What is the mechanism of action of H1-receptor antagonists in allergic rhinitis?

H1-receptor antagonists act primarily as inverse agonists at H1-receptors on nerve endings, smooth muscle, and glandular cells, blocking histamine-mediated symptoms of allergic rhinitis such as pruritus, sneezing, rhinorrhea, and vasodilation. Beyond competitive histamine blockade, multiple studies indicate these agents possess additional anti-inflammatory and immunomodulatory properties, including suppression of Th2 cytokines (e.g., IL-4), modulation of CD4+ T lymphocyte subsets, and reduction of proinflammatory mediators such as IL-6 and TNF-α. Second-generation agents (e.g., cetirizine, loratadine, desloratadine, levocetirizine) deliver these effects with minimal CNS penetration compared to first-generation antihistamines.

How it works

Allergen cross-linking of IgE on mast cells and basophils triggers degranulation and histamine release; H1-antagonists function as inverse agonists by binding H1-receptors and suppressing both histamine-stimulated and constitutive receptor activity, thereby preventing downstream signaling cascades responsible for nasal inflammation. Additional immunomodulatory effects — including upregulation of regulatory T cells and inhibition of Th2-skewed cytokine production — may contribute to sustained clinical benefit beyond acute histamine blockade.

Confidence: high

How quickly do different antihistamines reach peak effectiveness after dosing?

Antihistamines generally reach peak plasma concentrations within 1-3 hours after oral administration, though there is meaningful variation between agents. Second-generation antihistamines like cetirizine reach Tmax rapidly (0.5-1 hour), while others such as bilastine (1.1-1.4 hours), loratadine, and fexofenadine follow at 1-3 hours; first-generation agents are similarly absorbed quickly but their longer half-lives (e.g., ~20 hours for chlorpheniramine) can prolong CNS effects. Clinical onset of symptom relief, as measured by histamine wheal-and-flare suppression, broadly aligns with these pharmacokinetic profiles, with meaningful antihistaminic activity typically observed within 1-2 hours post-dose.

How it works

H1-receptor antagonists are absorbed through the gastrointestinal tract and competitively block peripheral and, for first-generation agents, central H1 receptors; peak receptor occupancy and pharmacodynamic effect correlate broadly with peak plasma concentrations, though tissue distribution and receptor binding kinetics can create a slight lag between Tmax and maximal clinical effect. Second-generation agents generally have lower CNS penetration due to P-glycoprotein efflux and protein binding characteristics, confining their primary effects to peripheral H1 receptors.

Confidence: moderate

Can nasal irrigation reduce allergen load?

Nasal irrigation with saline solutions effectively reduces allergen load in nasal passages through mechanical clearance, with a 2012 meta-analysis (Hermelingmeier et al.) demonstrating a 27.66% reduction in AR symptoms, 66% decrease in medication use, and 31.19% improvement in mucociliary clearance. Multiple RCTs and comparative studies confirm that nasal irrigation—particularly high-volume, low-pressure methods used 2–3 times daily—provides clinically meaningful symptom relief and, when combined with intranasal steroids, outperforms either treatment alone. High-volume irrigation (125–176 mL, 3x/day) in steroid-free AR patients has also been shown to prevent seasonal IgE elevation, suggesting direct attenuation of allergen-driven immune responses.

How it works

Saline irrigation mechanically dilutes and flushes allergens, inflammatory mediators, and mucus from nasal mucosa, preserving epithelial barrier integrity and limiting allergen penetration and subsequent IgE sensitization. Hypertonic solutions additionally reduce mucosal edema and restore impaired mucociliary clearance, further accelerating allergen removal from the nasal cavity.

Confidence: moderate

This article is general information about hayfever, not medical advice. It should not replace guidance from your GP, pharmacist or allergy specialist — particularly if you are pregnant, treating a child, or managing asthma alongside hayfever. Read our medical disclaimer.

Reading about it is one thing. Knowing your own season is another.

Haelo turns research like this into what to do today — based on your air, your patterns and your symptoms. Join the waitlist.

No spam. Unsubscribe any time. We'll only contact you about Haelo.